Evolent Health (NYSE:EVH – Free Report) had its target price trimmed by Canaccord Genuity Group from $47.00 to $45.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the technology company’s stock. A number of other equities analysts also recently weighed in on EVH. […]
Evolent Health, Inc. (NYSE:EVH – Get Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $29.77, but opened at $32.75. Evolent Health shares last traded at $31.81, with a volume of 258,344 shares trading hands. Wall Street Analyst Weigh In Several research firms recently weighed […]
Evolent Health, Inc. (NYSE:EVH) Q4 2023 Earnings Call Transcript February 22, 2024 Evolent Health, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Evolent Earnings Conference Call for the Quarter and Year-Ended December 31, 2023. As a […]